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INTRODUCTION
Asthma is an increasingly common health problem in adults 
and children.1,2 The prevalence of asthma has increased every 
year for the last five decades.3-5 A Korean survey showed that 
8.9% of the population has been diagnosed with asthma.6 Fur-
ther, the prevalence of asthma in Korea has increased from 5.7% 
in 1980 to 10.1% in 1990.6
Genetic (cytokine and immune response genes),7,8 develop-
mental, and environmental factors such as viral infections,9 al-
lergens,10 and occupational exposure11 have been associated 
with asthma susceptibility, age at onset, and severity. Although 
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the pathogenesis of the disease has not been fully elucidated, a 
major risk factor is the development of an immune response to 
a foreign antigen that is characterized by the production of an-
tigen-specific immunoglobulin E (IgE).12 IgE-mediated allergic 
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Purpose:  Atopy is an important cause of asthma. Few data on the prevalence of atopy or comparisons with clinical characteristics of asthma in 
Korean patients have been published. We evaluated the effects of atopy on clinical profiles and airway inflammation in Korean asthmatics.  Meth-
ods:  We retrospectively enrolled 1,492 asthmatics from the Cohort for Reality and Evolution of Adult Asthma in Korea (COREA) cohort who had un-
dergone skin prick tests for aeroallergens. The patients’ clinical characteristics, lung function, PC20, and sputum and blood inflammatory cell counts 
were compared based on the presence or absence of atopy. Atopy was defined as one or more positive reactions (A/H ratio >1) on a skin prick test. 
Results:  Among 11 aeroallergens, house dust mites (Dermatophagoides farinae and Dermatophagoides pteronyssinus) were the most prevalent 
cause of a positive skin prick test. As compared with non-atopic asthmatics, atopic asthmatics showed early onset of the disease. Atopic patients 
with asthma had a higher FEV1, FVC, and FEV1/FVC as compared with non-atopic patients with asthma. In addition, asthmatics without atopy had 
more uncontrolled asthma (P=0.001) and severe rhinitis (P<0.05) as compared with atopic asthmatics. Smoking, as measured in pack years, was 
higher in the non-atopic asthmatics than in the atopic asthmatics. The erythrocyte sedimentation rate was higher in non-atopic asthmatics than in 
the atopic asthmatics and patients with non-atopic asthma had a higher sputum neutrophil count than did those with atopic asthma.  Conclusions: 
Our data indicate that atopic asthmatics had an early onset of disease and high IgE levels, while the non-atopic asthmatics had decreased lung func-
tion and a high sputum neutrophil count, suggesting that a different approach is needed to treat atopic asthma.
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reactions to environmental allergens play an important role in 
the pathophysiology of asthma. Atopic persons have high levels 
of IgE that is reactive against one or more specific allergens and 
they often have increased plasma total IgE concentrations.13 
Moreover, the prevalence of asthma is closely related to serum 
IgE levels standardized for age and sex.14 Overwhelming evi-
dence has confirmed the role of IgE in atopic asthma, while a 
link between IgE and non-atopic asthma has also been report-
ed.15
Several studies have reported a strong relationship between 
exposure to house dust mites, the presence of serum IgE direct-
ed against mite allergens, and asthma.16-18 Epidemiological evi-
dence indicates that atopic asthma is correlated with a high se-
rum IgE level, although the contribution of allergen-specific IgE 
antibodies to the pathogenesis and severity of this disease is 
unclear. In the present study, we examined the prevalence of 
atopy and compared clinical characteristics and the presence 
of airway inflammation by atopy in the Cohort for Reality and 
Evolution of Adult Asthma in Korea (COREA) cohort asthmat-
ics.
 
MATERIALS AND METHODS
Subjects
The Corea is an eight-year (2005-2012), multicenter, prospec-
tive cohort study of asthmatics 19 years of age or older.19 
Patients were enrolled at 11 clinical centers in various regions 
of South Korea. The participating institutions were the Asan 
Medical Center at the University of Ulsan and the hospitals of 
Seoul National University, Bundang Seoul National University, 
Yonsei University, Chung-Ang University, Ewha Womans Uni-
versity, Hanyang University, Soonchunhyang University, Ajou 
University, The Catholic University of Korea, and Chonbuk Na-
tional University. We retrospectively studied the clinical data of 
2,588 asthma patients who were registered in the COREA co-
hort. Asthma was diagnosed based on GINA guidelines.20 All 
subjects had a clinical diagnosis of asthma that was supported 
by one or more of the following criteria: 1) variability in the 
maximum diurnal peak expiratory flow of >20% over the 
course of 14 days, 2) an increase in FEV1 of >15% after the in-
halation of 200-400 μg of albuterol, or 3) a 20% reduction in 
FEV1 in response to a provocative concentration of inhaled 
methacholine (PC20) of <25 mg/mL. Asthma control status 
and allergic rhinitis severity were classified to GINA guideline20 
and ARIA guideline.21 The subjects underwent a standardized 
assessment, including an analysis of induced-sputum speci-
mens, complete blood cell counts with differential counts, IgE 
concentrations, chest posteroanterior radiography, allergy skin 
prick tests, and spirometry. The body mass index (BMI) for each 
patient was calculated as weight (kg)/height (m2).22,23
The exclusion criteria were respiratory infection, COPD, vocal 
cord dysfunction, obstructive sleep apnea, Churg-Strauss syn-
drome, cardiac dysfunction, allergic bronchopulmonary asper-
gillosis, and poor adherence to treatment. All subjects were eth-
nic Koreans and required to provide written informed consent. 
The research protocol for this cohort study was approved by the 
Institutional Review Board (IRB) of each center.
Lung function
During a baseline visit, information regarding demographic 
characteristics was collected from all subjects, and spirometry 
was performed before and after the use of a bronchodilator. 
Baseline FVC and FEV1 measurements were obtained in the 
absence of recent bronchodilator use (within 8 hours). The bas-
al and post-bronchodilator FEV1, FVC, forced expiratory flow 
between 25 and 75% FVC (FEF25-75%), and DLCO were mea-
sured. FVC and FEV1 were measured at regular intervals of one 
or two months. We used Vmax Series 2130 Autobox Spirometry 
(Sensor Medics, Yorba Linda, CA, USA) and applied a calibra-
tion check every morning at 8:00 AM.
Allergy skin tests
Common inhalant allergens, including dust mites (Derma-
tophagoides farinae and Dermatophagoides pteronyssinus), Cat 
fur, Dog fur, Cockroache, Grass, Tree pollen (mixed), Ragweed, 
Mugwort, Alternaria, and Aspergillus spp. (Bencard Co., Brent-
ford, UK) were used for the skin prick test.24 Atopy was defined 
as having an allergen-induced wheal reaction equal to or great-
er than that caused by histamine (1 mg/mL) or equal to or 
greater than 3 mm in diameter. Total IgE was measured using 
the UniCAP system (Pharmacia Diagnostics, Uppsala, Swe-
den).
Sputum examination
Sputum samples were obtained for differential cell counts for 
patients in a stable state. Sputum was induced using isotonic 
saline containing a short-acting bronchodilator, and the sam-
ples were treated within 2 hours of collection as described pre-
viously.25 Briefly, all visible portions with greater solidity were 
carefully selected and placed in a pre-weighed Eppendorf tube. 
The samples were treated by adding eight volumes of 0.05% di-
thiothreitol (Sputolysin; Calbiochem Corp., San Diego, CA, USA) 
in Dulbecco’s phosphate-buffered saline (PBS). One volume of 
protease inhibitor (0.1 M EDTA and 2 mg/mL phenylmethyl-
sulfonylfluoride) was added to 100 volumes of the homogenized 
sputum, and the total cell count was determined with a hemo-
cytometer. The cells of the homogenized sputum were collect-
ed by cytocentrifugation, and 500 cells were examined on each 
sputum slide after staining with Diff-Quick (American Scientif-
ic Products, Chicago, IL, USA).
Statistical analysis
The data were double-entered into a statistical software pack-
age (SPSS, version 14.0; SPSS Inc., Chicago, IL, USA). The data 
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are expressed as the mean±standard deviation (SD) or stan-
dard error of the mean (SEM). Group differences in atopy were 
compared using a two-sample t-test, Mann-Whitney test, or 
Pearson’s χ2 test for normally distributed, skewed, or categorical 
data, respectively. Differences in the proportions of the patient 
populations were analyzed by the χ2 test with Fisher’s exact test 
when low expected cell counts were encountered. A P value<
0.05 was considered to be statistically significant.
RESULTS
Common inhalant allergen sensitization
House dust mites (D. farinae and D. pteronyssinus) were the 
most prevalent allergen on the skin prick test (Fig. 1). The per-
centage of atopic patients with sensitization to two or more al-
lergens was 39.3%. Total IgE levels were higher in atopic asth-
matics than in non-atopic asthmatics (514.2±32.2 vs. 293.7±
26.9 ku/L, P=0.001, Table 1).
Relationship between atopy and clinical variables
BMI was lower in atopic asthmatics than in non-atopic asth-
matics (23.5±0.11 vs. 24.4±0.25 kg/m2, P=0.001). Although 
the allergen sensitization number was correlated with the total 
IgE level (r=0.351, P=0.001) and total IgE was correlated with 
asthma severity (r=0.101, P=0.005), allergen sensitization was 
negatively correlated with asthma severity (r=-0.102, P=0.001). 
As compared with non-atopic asthmatics, atopic asthmatics 
showed early onset of the disease (30.2±0.45 vs. 43.1±0.65 
years, P<0.05). Cigarette smoking (in pack years) was higher in 
the non-atopic asthmatics than in the atopic asthmatics (23.3±
0.76 vs. 13.8±0.59, P=0.001). The erythrocyte sedimentation 
rate (ESR) was higher in the non-atopic asthmatics than in the 
atopic asthmatics (20.1±2.68 vs. 12.5±1.03 mm/hr, P=0.004, 
Fig. 2).
Relationship between atopy and severity of asthma and 
allergic rhinitis
Atopic patients with asthma had a higher FEV1 (83.5±0.68 vs. 
79.7±0.81% predicted, P=0.001), FVC (91.1±0.61 vs. 87.2±
0.65% predicted, P=0.001), and FEV1/FVC (90.8±0.81 vs. 84.3±
1.17%, P=0.001) as compared with non-atopic patients with 
asthma. Asthmatics without atopy had more uncontrolled asth-
ma (control status [n=atopy/non-atopy], controlled=185/177 
vs. partly controlled=326/289 vs. uncontrolled=127/200, P=
0.001, Fig. 3) and severe rhinitis as compared with atopic asth-
matics (severity [n=atopy/non-atopy], mild intermittent=
99/87 vs. moderate to severe intermittent=59/35 vs. mild per-
sistent=232/197 vs. moderate to severe persistent=68/83, P<
Table 1. Clinical and physiological variables in patients with bronchial asthma 
by atopy
Atopy (+) Atopy (-)
No. 751 741
Sex, male (%) 47.1%* 41.4%
Age (at initial visit) (yr) 39.7±0.50† 53.5±0.99
Duration of lung symptoms (yr) 9.53±0.41 10.4±0.52
BMI 23.5±0.11† 24.4±0.25
Initial FEV1, % pred. 83.5±0.68† 79.7±0.81
Initial FVC, % pred. 91.1±0.61† 87.2±0.65
Initial FEV1/FVC, % pred. 90.8±0.81† 84.3±1.17
Smoking status (none/ex/current)  359/238/154 357/278/106
Smoking (pack-yr) 13.8±0.59† 23.3±0.76
PC20, mg/mL 5.91±0.51 6.61±0.40
Total IgE, ku/L 514.2±32.2† 293.7±26.9
Blood eosinophils, % 9.0±2.53 4.7±0.20
Plus-minus values are the mean±standard error (SE). PC20 methacholine, the 
concentration of methacholine required to decrease the FEV1 by 20%. 
*Compared with asthmatic patients without atopy, P<0.05. †Compared with 
asthmatic patients without atopy, P<0.001.
FEV1, forced expiratory volume in one second; FVC, forced vital capacity; BMI, 
body mass index.
Fig. 1. Allergen prevalence according to an allergy skin test.
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Fig. 2. Differences in erythrocyte sedimentation rate (ESR) between atopic and 
non-atopic asthmatics.
100
80
60
40
20
0
Controlled Partly controlled Uncontrolled
(%)
P<0.001
atopy (+)
atopy (-)
Jang et al.
Allergy Asthma Immunol Res. 2013 May;5(3):143-149. http://dx.doi.org/10.4168/aair.2013.5.3.143
Volume 5, Number 3, May 2013
146 http://e-aair.org
0.05, Fig. 4).
Relationship between atopy and sputum inflammatory cells in 
patients with asthma
The atopic patients with asthma had a higher percentage of 
sputum lymphocytes (4.46±1.49 vs. 2.44±0.47%, P=0.001) 
than the non-atopic patients with asthma, and those patients 
with non-atopic asthma had a higher percentage of sputum 
neutrophils (36.0±2.28 vs. 25.3±2.02%, P=0.001) than those 
with atopic asthma (Table 2). There were no differences in PC20 
and blood eosinophils counts between the two groups. 
DISCUSSION
The results of this study suggest that atopy is associated with 
the severity of adult asthma and rhinitis, independent of airway 
hyperresponsiveness.
Asthmatics are typically classified as atopic or non-atopic 
based on sensitization to environmental aeroallergens. Howev-
er, atopic and non-atopic asthma are not well-separated dis-
ease entities.26 Although atopy is clearly a risk factor for the de-
velopment of asthma, only a small subset of subjects sensitized 
to aeroallergens express persistent symptoms, suggesting that 
additional pathogenic mechanisms such as respiratory viral in-
fections are involved as cofactors.27 In this study, house dust 
mites were the most prevalent allergen and atopy was related 
with the severity of asthma and allergic rhinitis in the COREA 
cohort. These results are consistent with the notion that the 
quantification of IgE antibodies may serve as a marker of asth-
ma severity.22 In this study, although allergen sensitization was 
correlated with total IgE levels and total IgE was correlated with 
asthma severity, the allergen sensitization number was nega-
tively correlated with asthma severity, indicating that not only 
IgE antibody levels, but also the number of allergens reacting 
positively when tested, are involved in asthma severity.23 In this 
study, the atopic asthmatics showed early disease onset and 
high IgE levels, indicating a role for allergen-specific IgE anti-
bodies in the pathogenesis of asthma and suggesting preven-
tive and therapeutic measures for asthma control.
Asthma and allergies in developing countries may be associ-
ated with the adoption of an urbanized “Western” lifestyle. To-
tal caloric intake is increasing with the industrialization of Ko-
rea, and BMI has been shown to be associated with wheezing 
in older adults living in rural areas of Korea.28 General obesity 
and central obesity are potential risk factors for asthma in rela-
tively non-obese Korean adults.29 Further, BMI has been shown 
to be associated with airway hyperresponsiveness in school-age 
boys. In this study, the BMI was lower in atopic asthmatics than 
in non-atopic asthmatics. In addition, the non-atopic asthmat-
ics were older and most were not obese, suggesting that Korean 
adult asthmatics are relatively non-obese.
Limited data regarding systemic inflammatory markers exist 
with respect to asthma. Some studies reported that systemic in-
flammatory markers were elevated in patients with non-aller-
gic asthma and obese patients with asthma.30
Measured systemic inflammation markers, including C-reac-
tive protein (CRP), total leukocyte count, and ESR were higher 
in patients with asthma and reduced by inhaled steroids plus 
an inhaled β2 agonist.31 One study showed that CRP was higher 
in patients with non-allergic asthma than in patients with aller-
gic asthma or healthy controls.32 Another study investigated the 
role of obesity in local and systemic inflammation in patients 
Fig. 3. Relationship between asthma severity and atopy status.
1=mild intermittent, 2=mild persistent, 3=moderate persistent, 4=severe 
persistent.
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Fig. 4. Relationship between rhinosinusitis severity and atopy status.
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week, 5=>5x/week.
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Table 2. Sputum differentials in patients with bronchial asthma by atopy
Atopy (+) Atopy (-)
No. 163 189
Total cells, no. 362.4±6.84* 393.6±13.1
Macrophages, %   50.8±2.54† 35.6±2.2
Neutrophils, % 25.3±2.0† 36.0±2.28
Eosinophils, % 11.0±1.29 10.8±1.31
Lymphocytes, % 4.46±1.49† 2.44±0.47
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with asthma.33 In this study, although the number of white 
blood cells did not differ between the atopic and non-atopic 
asthmatics, the ESR was higher in non-atopic asthmatics than 
in atopic asthmatics, indicating that systemic inflammation is 
involved in non-atopic asthma.
Cigarette smoking and asthma are associated with poor 
symptom control and impaired therapeutic responses to anti-
asthma drugs.34 In the developed world, approximately 25% of 
the population smokes cigarettes35,36 and an additional 25% are 
former smokers. Smoking rates are similar amongst adults with 
asthma.37-39 Higher levels are seen in patients with asthma that 
present to emergency departments with exacerbations.39 As 
compared with nonsmokers with asthma, those who smoke 
have worse symptom control,37,38 an accelerated decline in lung 
function,40,41 and an increased mortality rate.42 Asthmatic smok-
ers have more severe symptoms,36,37 a greater need for rescue 
medication,43 and worse health status indices as compared 
with never-smokers.43,44 In this study, non-atopic asthmatics 
had higher pack year values and more severe asthma, suggest-
ing that smoking contributes to difficulties in controlling asth-
ma.
Previous immunopathologic studies of patients with mild 
asthma that underwent bronchoscopic biopsy suggested that 
eosinophilic airway inflammation is a characteristic abnormal-
ity in both atopic and non-atopic asthma.45-47 However, other 
pathologic studies have suggested that neutrophils are present 
in higher quantities in the airways of patients with severe asth-
ma than in the airways of patients with mild asthma or in nor-
mal control subjects.48-50 In this study, although small group of 
asthmatic patients of total patients were included, non-atopic 
asthmatics had high sputum neutrophil counts, suggesting that 
sputum inflammatory cell numbers can be used as a guide in 
the treatment of asthmatics, and that the pathology in non-atop-
ic asthmatics is different from that in atopic asthmatics.
In conclusion, our study of a Korean cohort indicates that 
atopic asthmatics had an early onset of disease and high IgE 
levels, while non-atopic asthmatics had decreased lung func-
tion and a high sputum neutrophil count, suggesting that the 
treatment of asthma may be different by the atopic status of the 
patient.
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